1
Clinical Trials associated with CD147- CAR T cells(Peking University People's Hospital) / Not yet recruitingEarly Phase 1IIT A Pioneering Study on the Safety and Efficacy of CD147-Chimeric Antigen Receptor (CAR) T Cells in Patients With Relapsed or Refractory T-cell Non-Hodgkin's Lymphoma
The safety and preliminary effectiveness of CD147-CAR T cells in patients with relapsed or refractory T cell non-Hodgkin's lymphoma will be investigated in this pioneering study.
100 Clinical Results associated with CD147- CAR T cells(Peking University People's Hospital)
100 Translational Medicine associated with CD147- CAR T cells(Peking University People's Hospital)
100 Patents (Medical) associated with CD147- CAR T cells(Peking University People's Hospital)
100 Deals associated with CD147- CAR T cells(Peking University People's Hospital)